Philippe Hantraye

Title: The Innovations of Philippe Hantraye

Introduction

Philippe Hantraye is a notable inventor based in France. He has made significant contributions to the field of biomarker research, particularly in relation to peripheral benzodiazepine receptors. His work has implications for both normal and pathological conditions, showcasing the importance of innovative approaches in medical diagnostics.

Latest Patents

Philippe Hantraye holds a patent titled "Use Of 7-Chloro-N,n,5-Trimethyl-4-Oxo-3-Phenyl-3,5-Dihydro-4h-Pyridazino[4,5-B]indole-1-Acetamide As A Biomarker Of Peripheral Benzodiazepine Receptor Levels." This patent describes the use of a radiolabelled form of the compound as a biomarker for detecting PBR levels in individuals. The method outlined in the patent is crucial for diagnosing conditions associated with these receptor levels.

Career Highlights

Throughout his career, Philippe has worked with prominent companies such as Sanofi-Aventis and Commissariat à l'Énergie Atomique (CEA). His experience in these organizations has allowed him to develop and refine his innovative ideas in the field of medical research.

Collaborations

Philippe has collaborated with notable colleagues, including Jesus Benavides and Herve Boutin. These partnerships have contributed to the advancement of his research and the successful development of his patented technologies.

Conclusion

Philippe Hantraye's work exemplifies the intersection of innovation and medical science. His contributions to biomarker research are significant and continue to influence the field.